amyloidosis

(redirected from ATTR amyloidosis)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to ATTR amyloidosis: Hereditary amyloidosis, familial amyloidosis

am·y·loid·o·sis

 (ăm′ə-loi-dō′sĭs)
n.
Any of a group of diseases or conditions characterized by the formation and deposition of amyloid in various organs and tissues of the body.

amyloidosis

(ˌæmɪlɔɪˈdəʊsɪs)
n
(Pathology) pathol the deposition of amyloid in various tissues of the body, as occurs in certain chronic infections
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.amyloidosis - a disorder characterized by deposit of amyloid in organs or tissues; often secondary to chronic rheumatoid arthritis or tuberculosis or multiple myeloma
illness, sickness, unwellness, malady - impairment of normal physiological function affecting part or all of an organism
Translations

am·y·loi·do·sis

n. amiloidosis, acumulación de amiloide en los tejidos.

amyloidosis

n amiloidosis f
References in periodicals archive ?
Alnylam Pharmaceutical announced that additional results from the APOLLO Phase 3 study of patisiran, an investigational therapeutic for the treatment of hereditary ATTR amyloidosis, will be presented at the 16th International Symposium on Amyloidosis.
M2 PHARMA-February 6, 2018-FDA Accepts Alnylam NDA, Grants Priority Review Status for Patisiran for Treatment of Hereditary ATTR Amyloidosis
Sanofi will receive royalties based on net sales of these ATTR amyloidosis products.
Alnylam will obtain global development and commercialization rights to its investigational RNAi therapeutics programs for the treatment of ATTR amyloidosis, including patisiran and ALN-TTRsc02.